Loading...

Recombinant Human Biglycan (carrier-free)

Pricing & Availability
Regulatory Status
RUO
Other Names
BGN, Bone/cartilage proteoglycan I, PG-S1, small leucine-rich protein 1A, SLRR1A
Ave. Rating
Submit a Review
Product Citations
publications
Recom_Human_Biglycan_1_CF
Recombinant human Biglycan inhibits proliferation of 3T3-L1 (mouse embryonic fibroblast cells) in a dose-dependent mannner. The EC50 for this effect is 3 - 21 µg/mL.
  • Recom_Human_Biglycan_1_CF
    Recombinant human Biglycan inhibits proliferation of 3T3-L1 (mouse embryonic fibroblast cells) in a dose-dependent mannner. The EC50 for this effect is 3 - 21 µg/mL.
  • Recom_Human_Biglycan_2_CF
    Stability testing for Recombinant human Biglycan. Recombinant human Biglycan was aliquoted in PBS, pH 7.2 at 0.2 mg/mL and one aliquot was kept at 4°C (Control), and another was frozen and thawed four times (4x Freeze/Thaw). After this procedure, the samples were tested for their ability to inhibit proliferation of 3T3-L1 (mouse embryonic fibroblast cells) in a dose-dependent manner. The EC50 for this effect is 3 -21 µg/mL
Cat # Size Price Save
566804 25 µg ¥62,690
566806 100 µg ¥134,330
Description

Biglycan belongs to ‘class I’ small leucine-rich proteoglycans (SLRPs). The Biglycan gene has been mapped to the X chromosome and its protein core consists of 10 to 12 leucine-rich repeats (LRRs), which are flanked by cysteine-rich regions. Expressed ubiquitously in its precursor form, mature Biglycan is synthesized by the cleavage of an N-terminal propeptide by bone morphogenetic protein (BMP) 1. Under homeostasis, the majority of secreted Biglycan is bound to matrix fibers which can be cleaved by proteases and released under pathological conditions. Biglycan and decorin are recognized as proteins that can affect cell proliferation of pre-adipocytes. The two GAG chains of Biglycan binds collagen I much more efficiently than the Biglycan protein core or the decorin. Biglycan has been described to modulate tumor cell migration and invasion, overexpression leading to activation of ERK signaling pathway and upregulation of VEGF expression. Phenotypic readouts of this pathway include enhanced angiogenesis and tumor growth. Furthermore, binding of Biglycan to TLR2, TLR4, and CD14, mediates inflammation-dependent angiogenesis and affects interactions between the tumor parenchyma and stroma. 

Product Details
Technical data sheet

Product Details

Source
Human Biglycan, amino acids Asp38-Lys368 (Accession # P21810), with a C-terminal 6His tag was expressed in CHO cells.
Molecular Mass
The 340 amino acid recombinant protein has a predicted molecular mass of approximately 38.2 kD. The DTT-reduced and non-reduced protein migrates at approximately 50-60 kD in SDS-PAGE. The predicted N-terminal amino acid is Asp.
Purity
> 95%, as determined by Coomassie stained SDS-PAGE.
Formulation
0.22 µm filtered protein solution is in PBS, pH 7.2
Endotoxin Level
Less than 0.1 EU per μg of cytokine as determined by the LAL method
Concentration
25 µg size is bottled at 200 µg/mL. 100 µg size and larger sizes are lot-specific and bottled at the concentration indicated on the vial. To obtain lot-specific concentration and expiration, please enter the lot number in our Certificate of Analysis online tool.
Storage & Handling
Unopened vial can be stored between 2°C and 8°C for up to 2 weeks, at -20°C for up to six months, or at -70°C or colder until the expiration date. For maximum results, quick spin the vial prior to opening. The protein can be aliquoted and stored at -20°C or colder. Stock solutions can also be prepared at 50 - 100 μg/mL in appropriate sterile buffer, carrier protein such as 0.2 - 1% BSA or HSA can be added when preparing the stock solution. Aliquots can be stored between 2°C and 8°C for up to one week and stored at -20°C or colder for up to 3 months. Avoid repeated freeze/thaw cycles. Avoid repeated freeze/thaw cycles.
Activity
Human Biglycan inhibits proliferation of 3T3-L1 (mouse embryonic fibroblast cells) in a dose-dependent manner. EC50 of this effect is 3 - 21 µg/mL.
Application

Bioassay
Application Notes

BioLegend carrier-free recombinant proteins provided in liquid format are shipped on blue-ice. Our comparison testing data indicates that when handled and stored as recommended, the liquid format has equal or better stability and shelf-life compared to commercially available lyophilized proteins after reconstitution. Our liquid proteins are validated in-house to maintain activity after shipping on blue ice and are backed by our 100% satisfaction guarantee. If you have any concerns, contact us at tech@biolegend.com.

Antigen Details

Structure
Homodimer
Distribution

Expressed ubiquitously on cells

Function
Modulates tumor cell migration and invasion, mediates inflammation-dependent angiogenesis
Interaction
Monocytes/macrophages, erythrocytes, T and B lymphocytes, dendritic cells, Schwann cells
Ligand/Receptor
Collagen I, Toll-like receptors (TLR) 2 and 4, CD14 and CD44
Bioactivity
Human Biglycan inhibits proliferation of 3T3-L1 (mouse embryonic fibroblast cells) in a dose-dependent manner. EC50 of this effect is 3 - 21 µg/mL.
Cell Type
Endothelial cells, Epithelial cells, Fibroblasts
Biology Area
Angiogenesis, Signal Transduction
Molecular Family
Soluble Receptors
Antigen References
  1. McBride OW, et. al. 1990. Genomics. 6:219-25.
  2. Diehl V, et. al. 2021. Front. Oncol. 11: 801801.
  3. Scott IC, et. al. 2000. J Biol Chem. 275:30504-11.
  4. Schaefer L, et. al. 2005. J Clin. Investig. 115:2223-33.
  5. Raspanti M, et. al. 2008. J Struct. Biol. 164:134-9.
  6. Douglas T, et. al. 2006. Biomacromolecules. 7:2388-93.
  7. Ward M and Ajuwon KM. 2011. Cell Proliferation. 44:343-51.
  8. Hu L, et. al. 2014. Oncotarget. 5:1885-96.
  9. Wu H, et. al. 2023. Int J Biol Sci. 19:465-483.
  10. Guo D, et. al. 2019. Int J Mol Sci. 20:5716.
  11. Xing X, et. al. 2015. Tumour Biol. 36:1773-80.
Gene ID
633 View all products for this Gene ID
UniProt
View information about Biglycan on UniProt.org

Related FAQs

Why choose BioLegend recombinant proteins?

     • Each lot of product is quality-tested for bioactivity as indicated on the data sheet.
     • Greater than 95% Purity or higher, tested on every lot of product.
     • 100% Satisfaction Guarantee for quality performance, stability, and consistency.
     • Ready-to-use liquid format saves time and reduces challenges associated with reconstitution.
     • Bulk and customization available. Contact us.
     • Learn more about our Recombinant Proteins.

How does the activity of your recombinant proteins compare to competitors?

We quality control each and every lot of recombinant protein. Not only do we check its bioactivity, but we also compare it against other commercially available recombinant proteins. We make sure each recombinant protein’s activity is at least as good as or better than the competition’s. In order to provide you with the best possible product, we ensure that our testing process is rigorous and thorough. If you’re curious and eager to make the switch to BioLegend recombinants, contact your sales representative today!

What is the specific activity or ED50 of my recombinant protein?

The specific activity range of the protein is indicated on the product datasheets. Because the exact activity values on a per unit basis can largely fluctuate depending on a number of factors, including the nature of the assay, cell density, age of cells/passage number, culture media used, and end user technique, the specific activity is best defined as a range and we guarantee the specific activity of all our lots will be within the range indicated on the datasheet. Please note this only applies to recombinants labeled for use in bioassays. ELISA standard recombinant proteins are not recommended for bioassay usage as they are not tested for these applications.

Have your recombinants been tested for stability?

Our testing shows that the recombinant proteins are able to withstand room temperature for a week without losing activity. In addition the recombinant proteins were also found to withstand four cycles of freeze and thaw without losing activity.

Does specific activity of a recombinant protein vary between lots?

Specific activity will vary for each lot and for the type of experiment that is done to validate it, but all passed lots will have activity within the established ED50 range for the product and we guarantee that our products will have lot-to-lot consistency. Please conduct an experiment-specific validation to find the optimal ED50 for your system.

How do you convert activity as an ED50 in ng/ml to a specific activity in Units/mg?

Use formula Specific activity (Units/mg) = 10^6/ ED50 (ng/mL)

Go To Top Version: 1    Revision Date: 12/22/2023

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account